http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PA-8641601-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
filingDate 2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2345f813f68efc9efee4c9fd545be12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_295ed9234747fad690d8c713f00bff82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5a8a6255e1a91b95b488d6b43832d6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ac4e5ae65a47cfb5e0759aa2faa138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ec972985b98d1946e73cecc2ac23297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09201864bc0d902fda022e6dcf64478c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc468705cefd875b12f83daec44630e
publicationDate 2006-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PA-8641601-A1
titleOfInvention DERIVATIVES OF ACETIC ACID WITH CICLOHEXILMETOXI SUBSTITUTES, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT
abstract THE INVENTION REFERS TO ACETIC ACID DERIVATIVES WITH CICLOHEXILMETOXI SUBSTITUENTS AND PHYSIOLOGICALLY TOLERATED SALTS AND PHYSIOLOGICALLY FUNCTIONAL DERIVATIVES OF THE SAME. COMPOUNDS OF FORMULA IN WHICH THE RADICALS HAVE THE MEANINGS THAT ARE INDICATED, AND THE PHYSIOLOGICALLY TOLERATED SALTS OF THE SAME, AND THE PROCEDURES TO PREPARE THEM HAVE BEEN DESCRIBED. THE COMPOUNDS ARE ADEQUATE, FOR EXAMPLE, TO TREAT AND / OR PREVENT THE DISORDERS OF THE METABOLISM OF THE FATTY ACIDS AND THE DISORDERS OF THE USE OF THE GLUCOSE, AND THE DISORDERS IN WHICH THE INSULIN RESISTANCE IS IMPLIED.
priorityDate 2004-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054

Total number of triples: 29.